Angels in MedCity

For early-stage founders navigating the complexities of healthcare and life sciences funding, Angels in MedCity stands out as one of the UK's distinctive investor networks. Founded in 2014, this London-based angel investment group emerged from a collaboration between MedCity and London Business Angels (now part of Newable), with initial backing from the Mayor of London and the European Regional Development Fund.

Unlike typical angel syndicates, Angels in MedCity has carved out a clear niche: they exclusively support early-stage life sciences and health-tech startups, leveraging London's thriving "Golden Triangle" of leading universities and research institutions. Founders can expect to pitch to an audience deeply versed in medtech, biotech, diagnostics, therapeutics, and digital health.

The network doesn't simply provide capital; its hallmark is the comprehensive support founders receive, including mentorship, pitch preparation, and invaluable connections within academia, clinical research, and the NHS. Founders participating in their Investment Hub events are carefully vetted and coached beforehand, ensuring they're genuinely "investment-ready" and able to clearly articulate their vision and commercial viability.

Angels in MedCity doesn't usually lead investment rounds but co-invests with established partners such as the London Co-Investment Fund and other angel groups, typically participating in seed and pre-Series A rounds ranging from £250,000 to several million pounds. Notable successes include investments in startups like Desktop Genetics, which achieved a notable exit through acquisition, and innovative companies such as Clustermarket and The Electrospinning Company, which have significantly expanded their market presence after initial support from the network.

Founders who've raised funding through Angels in MedCity consistently highlight the value of the network's extensive support beyond money. Stephanie Monty and Toni Schneider from the medtech startup Ostique praised the network, noting how it helped them refine their pitch, expand their network, and successfully close their investment round. Similarly, Jean Marc Feghali of assistive tech company WeWALK credited MedCity's expansive healthcare network for unlocking critical investor relationships and strategic opportunities.

For UK-based healthcare founders aiming to accelerate their growth, Angels in MedCity offers a combination of capital, expertise, and industry connectivity. While founders should be prepared for a thorough vetting process, the potential rewards—beyond the cheque—could prove transformative, positioning startups for success in the competitive health-tech landscape.